PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
|Articles|June 19, 2013
Equipment and Processing Report
- Equipment and Processing Report-06-19-2013
- Volume 0
- Issue 0
June 2013 Editor's Picks: Products from Brabender Pharma and K-Tron
Equipment from Brabender Pharma and K-Tron
Brabender Pharma
Tabletop twin-screw extruder features easy cleaning.
Brabender Pharma’s PTSE 12/36 EC tabletop, 12-mm pharmaceutical twin-screw extruder is suitable for hot-melt extrusion (HME), early formulation development, and preparation of samples for clinical studies. The more compact addition to the company’s product line enhances the ability to address the challenges of HME in feasibility studies. The extruder has a removable barrel liner and a horizontally split barrel to allow quick access and ease of cleaning and sterilization. Two additional openings can be used as downstream feeding or venting ports. Segmented screws can be configured to customer specifications and optional ports can be added on request.
K-Tron
Micro-ingredient feeder has high accuracy for low feedrates.
Articles in this issue
about 13 years ago
Developments in Pharmaceutical Process Modelingabout 13 years ago
INTERPHEX Showcases Machine Innovationsabout 13 years ago
Evaluating Parenteral Packaging for Glass DelaminationRelated to this article
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.